Fatima Mir1, Faisal Mahmood2, Amna Rehana Siddiqui3, Shehla Baqi4, Syed Hani Abidi5, Abdul Momin Kazi6, Apsara Ali Nathwani6, Amerta Ladhani6, Farah Naz Qamar6, Sajid Bashir Soofi6, Sikander Ali Memon7, Jamila Soomro8, Saqib Ali Shaikh7, Victoria Simms9, Palwasha Khan10, Rashida Abbas Ferrand11. 1. Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan. Electronic address: fatima.mir@aku.edu. 2. Department of Medicine, Aga Khan University, Karachi, Pakistan. 3. Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan. 4. Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan. 5. Department of Basic and Biological Sciences, Aga Khan University, Karachi, Pakistan. 6. Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan. 7. Sindh AIDS Control Program, Sindh, Pakistan. 8. Ministry of Health, Sindh, Pakistan. 9. Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. 10. Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK. 11. Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Abstract
BACKGROUND: In April 2019, an HIV screening camp for all ages was established in response to a report of an unusually large number of paediatric HIV diagnoses in Larkana, Pakistan. We aimed to understand the clinical profile of the children who registered for HIV care. METHODS: In this cross-sectional study, we review the outbreak response from the government, academia, and UN agencies in Larkana, Sindh, Pakistan. We report age-stratified and sex-stratified HIV prevalence estimated among individuals screened. For children who registered for HIV care, clinical history of previous injections and blood transfusions, HIV disease stage, hepatitis B and hepatitis C status, and CD4 count was abstracted from clinical records from Sindh AIDS Control Program HIV Clinic (Shaikh Zayed Childrens Hospital, Larkana, Pakistan) and analysed using percentages, χ2 tests, and weight-for-age Z scores. We also analysed data for parents who were tested for HIV. FINDINGS: Between April 24, and July 15, 2019, 31 239 individuals underwent HIV testing, of whom 930 (3%) tested positive for HIV. Of these, 763 (82%) were younger than 16 years and 604 (79%) of these were aged 5 years and below. Estimated HIV prevalence was 3% overall; 7% (283 of 3803) in children aged 0-2 years, 6% (321 of 5412) in children aged 3-5 years, and 1% (148 of 11 251) in adults aged 16-49 years. Of the 591 children who registered for HIV care, 478 (81%) were 5 years or younger, 379 (64%) were boys, and 315 (53%) of 590 had a weight-for-age Z score of -3·2. Prevalence of hepatitis B surface antigen was 8% (48 of 574) and hepatitis C antibody positivity was 3% (15 of 574). Of children whose mothers tested for HIV, only 39 (11%) of 371 had HIV-positive mothers. Most children (404 [89%] of 453) reported multiple previous injections and 40 (9%) of 453 reported blood transfusions. INTERPRETATION: This HIV outbreak is unprecedented among children in Pakistan: a 54% increase in paediatric HIV diagnoses over the past 13 years. The outbreak was heavily skewed towards young children younger than 5 years, with a predominance of boys. Epidemiological and molecular studies are needed to understand the full extent of the outbreak and its drivers to guide HIV control strategies. FUNDING: None.
BACKGROUND: In April 2019, an HIV screening camp for all ages was established in response to a report of an unusually large number of paediatric HIV diagnoses in Larkana, Pakistan. We aimed to understand the clinical profile of the children who registered for HIV care. METHODS: In this cross-sectional study, we review the outbreak response from the government, academia, and UN agencies in Larkana, Sindh, Pakistan. We report age-stratified and sex-stratified HIV prevalence estimated among individuals screened. For children who registered for HIV care, clinical history of previous injections and blood transfusions, HIV disease stage, hepatitis B and hepatitis C status, and CD4 count was abstracted from clinical records from Sindh AIDS Control Program HIV Clinic (Shaikh Zayed Childrens Hospital, Larkana, Pakistan) and analysed using percentages, χ2 tests, and weight-for-age Z scores. We also analysed data for parents who were tested for HIV. FINDINGS: Between April 24, and July 15, 2019, 31 239 individuals underwent HIV testing, of whom 930 (3%) tested positive for HIV. Of these, 763 (82%) were younger than 16 years and 604 (79%) of these were aged 5 years and below. Estimated HIV prevalence was 3% overall; 7% (283 of 3803) in children aged 0-2 years, 6% (321 of 5412) in children aged 3-5 years, and 1% (148 of 11 251) in adults aged 16-49 years. Of the 591 children who registered for HIV care, 478 (81%) were 5 years or younger, 379 (64%) were boys, and 315 (53%) of 590 had a weight-for-age Z score of -3·2. Prevalence of hepatitis B surface antigen was 8% (48 of 574) and hepatitis C antibody positivity was 3% (15 of 574). Of children whose mothers tested for HIV, only 39 (11%) of 371 had HIV-positive mothers. Most children (404 [89%] of 453) reported multiple previous injections and 40 (9%) of 453 reported blood transfusions. INTERPRETATION: This HIV outbreak is unprecedented among children in Pakistan: a 54% increase in paediatric HIV diagnoses over the past 13 years. The outbreak was heavily skewed towards young children younger than 5 years, with a predominance of boys. Epidemiological and molecular studies are needed to understand the full extent of the outbreak and its drivers to guide HIV control strategies. FUNDING: None.
Authors: Govinda Khatri; Abdul Moiz Sahito; Mishal Shan Siddiqui; Minaam Farooq; Rida Fatima; Qasim Mehmood; Mohammad Mehedi Hasan Journal: Ann Med Surg (Lond) Date: 2022-05-26
Authors: Amy L Slogrove; Barbara Burmen; Mary Ann Davies; Andrew Edmonds; Elaine J Abrams; Ellen G Chadwick; Tessa Goetghebuer; Lynne M Mofenson; Mary E Paul; Claire Thorne; Paige L Williams; Marissa Vicari; Kathleen M Powis Journal: Clin Infect Dis Date: 2022-08-25 Impact factor: 20.999
Authors: Aaron G Lim; Adam Trickey; Laura H Thompson; Faran Emmanuel; Tahira E Reza; Rosy Reynolds; François Cholette; Dessalegn Y Melesse; Chris Archibald; Paul Sandstrom; James F Blanchard; Peter Vickerman Journal: Open Forum Infect Dis Date: 2021-09-02 Impact factor: 3.835
Authors: Arshad Altaf; Muhammad Safdar Kamal Pasha; Ayesha Majeed; Wajid Ali; Ahmed Sabry Alaama; Muhammad Shahid Jamil Journal: PLoS One Date: 2022-07-08 Impact factor: 3.752
Authors: Amna R Siddiqui; Apsara Ali Nathwani; Syed H Abidi; Syed Faisal Mahmood; Iqbal Azam; Sobiya Sawani; Abdul M Kazi; Aneeta Hotwani; Sikander Ali Memon; Jamila Soomro; Saqib Ali Shaikh; Baseer Achakzai; Quaid Saeed; Victoria Simms; Palwasha Khan; Rashida Ferrand; Fatima Mir Journal: BMJ Open Date: 2020-03-25 Impact factor: 2.692